Drug Trial Radar · NCT00000748
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
Last checked: Nov 19, 2026Latest source record: Nov 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,500
Actual
Start
Not stated
Primary completion
Not stated
Study completion Nov 1996
Sponsor
- Sponsor type
- NIH
- Collaborators
- Glaxo Wellcome
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Model
- Parallel
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To compare the safety and efficacy of two dosage regimens (daily and thrice-weekly) of sulfamethoxazole/trimethoprim (SMX/TMP; TMS) in the prevention of Pneumocystis carinii pneumonia (PCP) in high-risk HIV-infected patients. Previous tests have shown that SMX/TMP given daily is effective in preventing recurrence of PCP and may be effective in preventing PCP in patients who have never developed it. Because SMX/TMP can cause side effects, this study will attempt to determine the safest and most effective dose of this combination.
Conditions
- Pneumonia, Pneumocystis Carinii
- HIV Infections
Interventions
Sulfamethoxazole-TrimethoprimDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Community Consortium of San Francisco
San Francisco, California
Stanford Univ School of Medicine
Stanford, California
Denver CPCRA / Denver Public Hlth
Denver, Colorado
Wilmington Hosp / Med Ctr of Delaware
Wilmington, Delaware
Veterans Administration Med Ctr / Regional AIDS Program
Washington D.C., District of Columbia
AIDS Research Consortium of Atlanta
Atlanta, Georgia
AIDS Research Alliance - Chicago
Chicago, Illinois
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med
New Orleans, Louisiana
Baltimore Trials
Baltimore, Maryland
Univ of Maryland at Baltimore
Baltimore, Maryland
Comprehensive AIDS Alliance of Detroit
Detroit, Michigan
Henry Ford Hosp
Detroit, Michigan
Southern New Jersey AIDS Cln Trials / Dept of Med
Camden, New Jersey
North Jersey Community Research Initiative
Newark, New Jersey
Partners Research
Albuquerque, New Mexico
Univ Hosp / HIV - ID Clinic
Albuquerque, New Mexico
Addiction Research and Treatment Corp
Brooklyn, New York
Clinical Directors Network of Region II
New York, New York
Harlem AIDS Treatment Group / Harlem Hosp Ctr
New York, New York
Bronx Lebanon Hosp Ctr
The Bronx, New York
Portland Veterans Adm Med Ctr / Rsch & Education Grp
Portland, Oregon
Philadelphia FIGHT
Philadelphia, Pennsylvania
Richmond AIDS Consortium
Richmond, Virginia
Univ of Washington / Pacific Med Ctr
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.